Recombinant MUC4 antibody (AA 1729-1860)
Quick Overview for Recombinant MUC4 antibody (AA 1729-1860) (ABIN8093344)
Target
See all MUC4 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1729-1860
-
Purpose
- MUC4 Antibody / Mucin 4
-
Purification
- Protein A affinity
-
Immunogen
- A recombinant fragment (around amino acids 1729-1860) of human MUC4 protein (exact sequence is proprietary) was used as the immunogen for the recombinant Sialomucin Complex Subunit 4 antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Application Notes
-
1. Optimal dilution of the recombinant Sialomucin Complex Subunit 4 antibody should be determined by the researcher.
2. This recombinant Sialomucin Complex Subunit 4 antibody is recombinantly produced by expression in CHO cells. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.05 % BSA, 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Sialomucin Complex Subunit 4 antibody with sodium azide - store at 2 to 8oC, antibody without sodium azide - store at -20 to -80oC.
-
-
- MUC4 (Mucin 4, Cell Surface Associated (MUC4))
-
Alternative Name
- MUC4
-
Background
-
Sialomucin Complex Subunit 4 antibody targets Mucin-4, a large transmembrane glycoprotein encoded by the human MUC4 gene and a member of the membrane-bound mucin family. Sialomucin complex subunit 4 refers to the membrane-associated component of the heterodimeric MUC4 complex that was originally characterized as part of the ascites sialoglycoprotein system. In the literature, Sialomucin Complex Subunit 4 antibody, MUC4 antibody, and Mucin-4 antibody are used to describe detection of the same epithelial mucin protein that plays critical roles in barrier function and tumor biology.
MUC4 is synthesized as a high molecular weight precursor that undergoes proteolytic processing into two subunits that remain non-covalently associated at the cell surface. These are historically described as ASGP-1 and ASGP-2, with Sialomucin complex subunit 4 corresponding to the membrane-spanning ASGP-2 component. The extracellular region contains heavily O-glycosylated tandem repeat domains that contribute to mucosal protection, while the membrane-associated subunit contains epidermal growth factor-like domains, a transmembrane region, and a cytoplasmic tail involved in intracellular signaling. Sialomucin Complex Subunit 4 antibody is therefore valuable for investigating epithelial differentiation and membrane-associated signaling pathways.
In normal tissues, Mucin-4 expression is largely restricted to glandular and ductal epithelial cells of the respiratory, gastrointestinal, and genitourinary tracts. During malignant transformation, MUC4 expression frequently becomes upregulated and loses apical polarity, contributing to altered cell adhesion, increased tumor cell survival, and enhanced metastatic potential. Elevated MUC4 expression has been documented in pancreatic, breast, lung, ovarian, gastric, and colorectal carcinomas.
Mucin-4 has been shown to interact with receptor tyrosine kinases such as ERBB2, modulating downstream pathways that regulate proliferation and resistance to apoptosis. A Sialomucin Complex Subunit 4 antibody such as clone MUC4/8660R is suitable for detecting MUC4 expression in epithelial tissues and tumor biology research applications. -
UniProt
- Q99102
-
Pathways
- Regulation of Leukocyte Mediated Immunity
Target
-